hydroxychloroquine has been researched along with Acute Myelogenous Leukemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Carew, JS; Espitia, C; Jones, TM; Nawrocki, ST; Wang, W | 1 |
| Azzari, C; Bortone, B; Casini, T; Favre, C; Galli, L; Moriondo, M; Pegoraro, F; Sieni, E; Tondo, A | 1 |
| Anderson, EJ; Edara, VV; Grubbs, G; Khurana, S; Lapp, SA; Patel, PA; Pauly, MG; Piantadosi, A; Rostad, CA; Sabnis, HS; Stokes, CL; Suthar, MS | 1 |
| Coffer, PJ; Folkerts, H; Hilgendorf, S; Jaques, J; Mulder, AB; Schuringa, JJ; Vellenga, E; Wierenga, ATJ | 1 |
| Cheong, JW; Eom, JI; Jang, JE; Jeung, HK; Kim, JS; Kim, Y; Kim, YS; Min, YH | 1 |
| Cheong, JW; Eom, JI; Jeung, HK; Kim, Y; Min, YH | 1 |
6 other study(ies) available for hydroxychloroquine and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies.
Topics: Animals; Antineoplastic Agents; Autophagy; Azacitidine; Carcinoma, Renal Cell; Cell Line, Tumor; Hydroxychloroquine; Kidney Neoplasms; Leukemia, Myeloid, Acute; Lysosomes; Mice | 2019 |
Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression.
Topics: Antineoplastic Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Hydroxychloroquine; Immune Tolerance; Infant; Leukemia, Myeloid, Acute; Lopinavir; Pandemics; Pneumonia, Viral; Ritonavir; SARS-CoV-2 | 2020 |
Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
Topics: Adenosine Monophosphate; Adolescent; Alanine; Antimalarials; Antineoplastic Agents; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Disease Management; Humans; Hydroxychloroquine; Hydroxyurea; Leukemia, Myeloid, Acute; Male; SARS-CoV-2; Young Adult | 2021 |
Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
Topics: Animals; Antigens, CD34; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 5; Autophagy-Related Protein 7; bcl-2-Associated X Protein; Bone Marrow Cells; Cell Line, Tumor; Female; Humans; Hydroxychloroquine; Leukemia, Myeloid, Acute; Mice; Mice, Inbred NOD; Neoplastic Stem Cells; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; RNA Interference; Tumor Suppressor Protein p53 | 2017 |
Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine.
Topics: Antimetabolites, Antineoplastic; Autophagy; Cell Death; Cytarabine; Drug Resistance, Neoplasm; Humans; Hydroxychloroquine; Leukemia, Myeloid, Acute; U937 Cells | 2015 |
Enhanced autophagy in cytarabine arabinoside-resistant U937 leukemia cells and its potential as a target for overcoming resistance.
Topics: Antimetabolites, Antineoplastic; Autophagy; Blotting, Western; Cytarabine; Drug Resistance, Neoplasm; Genes, Reporter; Green Fluorescent Proteins; Humans; Hydroxychloroquine; Leukemia, Myeloid, Acute; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Microtubule-Associated Proteins; U937 Cells | 2016 |